Edition:
United States

Boule Diagnostics AB (BOUL.ST)

BOUL.ST on Stockholm Stock Exchange

323.00SEK
22 Jun 2017
Change (% chg)

6.00kr (+1.89%)
Prev Close
317.00kr
Open
324.00kr
Day's High
328.50kr
Day's Low
315.00kr
Volume
4,309
Avg. Vol
11,285
52-wk High
378.00kr
52-wk Low
79.00kr

BOUL.ST

Chart for BOUL.ST

About

Boule Diagnostics AB is a Sweden-based company engaged in the provision of medical diagnostic and testing equipment. The Company specializes in the development, manufacture and sale of complete blood count (CBC) systems in the field of hematology. It provides reagents, cleaning products and blood calibrators and controls that... (more)

Overall

Beta: 1.12
Market Cap(Mil.): kr1,520.41
Shares Outstanding(Mil.): 4.71
Dividend: 1.40
Yield (%): 0.43

Financials

  BOUL.ST Industry Sector
P/E (TTM): 40.42 38.58 19.12
EPS (TTM): 7.99 -- --
ROI: 15.88 8.76 -5.05
ROE: 17.91 13.56 -4.29

BRIEF-Boule Diagnostics closes factory in China

* BOULE DIAGNOSTICS OPTIMIZES MANUFACTURING STRUCTURE - CLOSES FACTORY IN CHINA

May 16 2017

BRIEF-Boule Diagnostics Q1 operating profit rises to SEK 12.0 mln

* Q1 NET SALES SEK 106.6 MILLION VERSUS SEK 84.4 MILLION YEAR AGO

May 11 2017

BRIEF-Boule Diagnostics wins strategic contract

* Installation of instruments will begin in Q2 2017 Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Mar 17 2017

BRIEF-Boule Diagnostics Q4 operating profit grows to SEK 1.3 mln

* Q4 net sales 105.8 million Swedish crowns ($11.89 million) versus 88.4 million crowns year ago

Feb 16 2017

BRIEF-Boule Diagnostics Q4 operating profit up at SEK 1.3 mln

* Q4 net sales 105.8 million Swedish crowns ($12 million)versus 88.4 million crowns year ago

Feb 16 2017

BRIEF-Boule Diagnostics presents new targets, adjusts dividend policy

* Said on Wednesday had revised its financial targets and adjusted dividend policy

Feb 16 2017

BRIEF-Boule Diagnostics wins new contract in India

Jan 18 Boule Diagnostics AB : * Wins new procurement in India * Systems will be delivered during first quarter of 2017 Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Jan 18 2017

BRIEF-Tredje AP-fonden buys 7.6 pct stake in Boule Diagnostics

* Says Tredje AP-fonden buys 358,068 shares in Boule Diagnostics AB corresponding to 7.6 percent stake

Jan 17 2017

BRIEF-Boule Diagnostics names Fredrik Dalborg new CEO

* Dalborg to replace Ernst Westman, who will leave CEO post and company in Q1 Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Jan 10 2017

More From Around the Web

Earnings vs. Estimates